Cite
APA Citation
Jochems, A., Martinez-Feito, A., Plasencia, C., Hernández-Breijo, B., Mezcúa, A., Villalba, A., Monjo, I., Nozal, P., Balsa, A., & Pascual-Salcedo, M. (n.d.). sAT0141 Optimal circulating adalimumab levels range associated with good clinical response in rheumatoid arthritis patients. Annals of the rheumatic diseases, 76, 822. http://access.bl.uk/ark:/81055/vdc_100135150817.0x00005a